Clinical trials
Completed Disorders of Excessive Somnolence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
123 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2003 | 5 |
| 2004 | 11 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 5 |
| 2009 | 7 |
| 2010 | 10 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 4 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 123 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cephalon | 13 |
| Bioprojet | 11 |
| Axsome Therapeutics, Inc. | 5 |
| Jazz Pharmaceuticals | 5 |
| Duke University | 3 |
| Hospices Civils de Lyon | 3 |
| Northwestern University | 3 |
| University of Pennsylvania | 3 |
| Avadel | 2 |
| Emory University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disorders of Excessive Somnolence | 123 |
| Narcolepsy | 36 |
| Sleep Apnea, Obstructive | 26 |
| Sleep Wake Disorders | 20 |
| Cataplexy | 16 |
| Sleep Initiation and Maintenance Disorders | 12 |
| Parkinson Disease | 10 |
| Sleep Apnea Syndromes | 9 |
| Parasomnias | 8 |
| Idiopathic Hypersomnia | 7 |
Trials
Showing 1 to 25 of 123. Each trial links to its page on Pharma Observatory.
23 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.